Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This evolving evidence base suggests a potential paradigm shift in the management of OSA, where pharmacotherapy could play a central role alongside established device therapies
Clinical Diabetes
No cost, no obligation
Dont fall into the trap of avoiding them
Indications and Usage Saxenda (liraglutide [rDNA origin] injection) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or greater (obese) or 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
US$ 22.36
)
US$ 25.24
US$ 26.09
US$ 29.95
US$ 20.10
